COMMUNIQUÉS West-GlobeNewswire

Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates
11/03/2019
Completed end-of-Phase 2 FDA meeting for molluscum contagiosum Meeting minutes received and support second quarter 2019 pivotal Phase 3 initiation Finalizing establishment of Irish entity to enable EU regulatory and [...]
Tauriga Sciences, Inc. Officially Launches its E-Commerce Site for the Sale of its CBD Infused Chewing Gum: Tauri-Gum
11/03/2019
Website: WWW.TAURIGUM.COM NEW YORK, NY, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development [...]
Tyme Technologies To Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
11/03/2019
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing metabolic-based cancer therapies, announced that management will present a corporate [...]
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference
11/03/2019
FRAMINGHAM, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Strongbridge Biopharma plc Announces Top-Line Results from Extended Evaluation Phase of the Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Potential Treatment of Endogenous Cushing’s Syndrome
11/03/2019
~ Extended Evaluation Phase Meets Objective of Showing Positive Long-Term Benefit-Risk Profile of RECORLEV™ (levoketoconazole) ~ ~ Favorable Liver-Related Findings: No Patients Experienced an Increase in Either Alanine [...]
La Jolla Pharmaceutical Company Appoints Darryl Wellinghoff as Chief Commercial Officer
11/03/2019
SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Marinus Pharmaceuticals Provides Business Update and 2018 Financial Results
11/03/2019
RADNOR, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]
Organogenesis Holdings Inc. to Present at Oppenheimer’s 29th Annual Healthcare Conference
11/03/2019
CANTON, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
TG Therapeutics to Present at the Cowen 39th Annual Health Care Conference
11/03/2019
Presentation scheduled for Wednesday, March 13, 2019, at 11:20 AM ET NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive [...]
Horizon Discovery to Present at the 2019 Cowen Health Care Conference
11/03/2019
Horizon Discovery Group plc Horizon Discovery to Present at the 2019 Cowen Health Care Conference Cambridge, UK, 11 March 2019: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group" or "Company"), a global [...]
Anavex Life Sciences Reaches 50% Enrollment Threshold in ANAVEX®2-73 Parkinson’s Disease Dementia (PDD) Phase 2 Study Ahead of Schedule
11/03/2019
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
11/03/2019
CHESTERBROOK, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) , a biopharmaceutical company focused on the development and commercialization of innovative treatment options that target and treat [...]
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
11/03/2019
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 18, 2019
08/03/2019
WAYNE, Pa., March 08, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on dermatological and immuno-inflammatory diseases, today announced it will [...]
UPDATE - electroCore Appointments Multiple Industry Veterans to Key Management Positions
08/03/2019
Dr. Tony Fiorino to serve as Chief Medical Officer and Brian Posner as Chief Financial Officer BASKING RIDGE, N.J., March 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic [...]
Sanofi: Filing of the 2018 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report
08/03/2019
Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Filing of the 2018 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report PARIS, France - March 8, 2019 - Sanofi announces [...]
Sanofi : Dépôt du Document de Référence 2018, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
08/03/2019
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Dépôt du Document de Référence 2018, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris (France) - Le 8 mars 2019 - Sanofi [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
08/03/2019
BURLINGTON, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in four investor conferences in March. JJ Pellegrino, Chief Financial Officer, is [...]
Audited Financial Statements' Announcement for The Year Ended 31 December 2018
08/03/2019
EASTPHARMA LTD. London, 8 March 2019 - EASTPHARMA (EAST LI) announces that it is releasing its audited financial statements for the year ended 31 December 2018 and a review of its main subsidiary DEVA Holding's audited [...]

Pages